Pulse Biosciences Inc Ano de IPO
Qual é o Ano de IPO de Pulse Biosciences Inc?
O Ano de IPO de Pulse Biosciences Inc é 2016
Qual é a definição de Ano de IPO?
A oferta pública inicia (OPI)l é um tipo de oferta pública em que as ações de uma empresa geralmente são vendidas a investidores institucionais que, por sua vez, vendem para o público em geral, em uma bolsa de valores, pela primeira vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Ano de IPO de empresas na Setor Health Care em NASDAQ em comparação com Pulse Biosciences Inc
O que Pulse Biosciences Inc faz?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Empresas com ano de ipo semelhantes a Pulse Biosciences Inc
- The Toronto-Dominion Bank PFD SER 9 3.7% tem Ano de IPO de 2015
- Fura Gems tem Ano de IPO de 2015
- Hostess Brands tem Ano de IPO de 2015
- Nabriva Therapeutics Plc tem Ano de IPO de 2015
- REF tem Ano de IPO de 2015
- H-Source tem Ano de IPO de 2015
- Pulse Biosciences Inc tem Ano de IPO de 2016
- American Pacific Borates tem Ano de IPO de 2017
- Razer tem Ano de IPO de 2017
- DEAG Deutsche Entertainment Aktiengesellschaft tem Ano de IPO de 2017
- Hamilton Beach Brands Co tem Ano de IPO de 2017
- Artelo Biosciences tem Ano de IPO de 2017
- VARTA AG tem Ano de IPO de 2017